Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+22.4%
5Y CAGR+81.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+22.4%/yr
Annual compound
5Y CAGR
+81.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
19.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $268.72M | -21.7% |
| 2024 | $343.15M | +66.8% |
| 2023 | $205.68M | +40.5% |
| 2022 | $146.38M | +101.8% |
| 2021 | $72.54M | +432.4% |
| 2020 | $13.63M | -8.6% |
| 2019 | $14.90M | - |